The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly

  1. Bernabeu, I.
  2. Alvarez-Escolá, C.
  3. Quinteiro, C.
  4. Lucas, T.
  5. Puig-Domingo, M.
  6. Luque-Ramírez, M.
  7. De Miguel-Novoa, P.
  8. Fernandez-Rodriguez, E.
  9. Halperin, I.
  10. Loidi, L.
  11. Casanueva, F.F.
  12. Marazuela, M.
Journal:
Journal of Clinical Endocrinology and Metabolism

ISSN: 0021-972X 0021-972X

Year of publication: 2010

Volume: 95

Issue: 1

Pages: 222-229

Type: Article

DOI: 10.1210/JC.2009-1630 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals